Dyne therapeutics market cap
WebFeb 28, 2024 · Latest Dyne Therapeutics Inc Stock News. As of February 28, 2024, Dyne Therapeutics Inc had a $681.8 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. Dyne Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last …
Dyne therapeutics market cap
Did you know?
WebComplete Dyne Therapeutics Inc. stock information by Barron's. View real-time DYN stock price and news, along with industry-best analysis. ... Market Cap. Vertex Pharmaceuticals Inc.-1.62 % $76 ... WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. ... Market Cap Shares Average Volume EPS; $9.38: $9.11: $4.30 - $15.63 ...
WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. WebDyne Therapeutics Inc market cap is $489.02M. What is the 52-week high for Dyne Therapeutics Inc? 52 week high is the highest price of a stock in the past 52 weeks, or …
WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. WebApr 7, 2024 · See the latest Dyne Therapeutics Inc Ordinary Shares stock price (NASDAQ:DYN), related news, valuation, dividends and more to help you make your …
WebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with …
WebFounded. 2024. Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. the project gutenberg ebook of a doll\u0027s houseWebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's stock … the project gutenberg ebook tapestry roomWebApr 5, 2024 · Dyne Therapeutics, Inc. Common Stock (DYN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. the project guest presentersWebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis. the project guestsWebMar 23, 2024 · DYN Complete Dyne Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Market Cap $646.76M; Shares Outstanding … the project guests last nightWebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. signature design by ashley swivel chairWebOur data points out that Dyne Therapeutics, Inc. (DYN) is ranked #5407 out of 13000 companies on February - 2024. DYN's Market Capitalization is $700 million and the … the project gutenberg ebook of the republic